2020 Press Releases Archive

Avantor Appoints Frederic Vanderhaegen Executive Vice President, Americas and Europe

September 22, 2020

Avantor to Present at the Morgan Stanley Virtual Healthcare Conference

September 01, 2020

Avantor to Present at the 2020 Wells Fargo Virtual Healthcare Conference

August 31, 2020

Avantor Announces Pricing of Upsized Secondary Offering

August 20, 2020

Avantor Announces Secondary Offering of 38,500,000 Shares of Common Stock

August 19, 2020

Avantor Announces Credit Rating Upgrade by S&P Global Ratings

August 10, 2020

Avantor Reports Second Quarter 2020 Results

July 29, 2020

Avantor Declares Dividend on Mandatory Convertible Preferred Stock

July 21, 2020

Avantor Announces Upsizing and Pricing of Offering of $2.0 Billion Equivalent of Senior Notes

July 07, 2020

Avantor Announces Preliminary Second Quarter 2020 Unaudited Revenue

July 07, 2020

Avantor Announces Offering of Senior Notes

July 07, 2020

Avantor to Report Second Quarter Earnings and Host Earnings Call on Wednesday, July 29, 2020

July 01, 2020

Avantor Expands Life Sciences Innovation Center to Address Bioprocessing Needs in Protein Science, Monoclonal Antibodies (mAbs), Cell and Gene Therapy

June 30, 2020

Avantor Named to Fortune 500 List

June 23, 2020

Avantor Announces Closing of Secondary Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

May 26, 2020

Avantor Announces Credit Rating Upgrade by Fitch Ratings

May 22, 2020

Avantor Announces Pricing of Secondary Offering

May 20, 2020

Avantor Announces Secondary Offering of 45,000,000 Shares of Common Stock

May 18, 2020

Avantor Reports First Quarter 2020 Results

April 29, 2020

Avantor and the Avantor Foundation Provide Support to Address Coronavirus (COVID-19) Pandemic

April 23, 2020

Avantor Appoints Tommy Thomas as Vice President, Investor Relations

March 23, 2020

Avantor Launches New Protein A Chromatography Resin – PROchievA

March 18, 2020

Avantor Reports Fourth Quarter and Full-Year 2019 Results

February 07, 2020

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.